231 related articles for article (PubMed ID: 30827375)
1. Identification and evaluation of antivirals for Rift Valley fever virus.
Lang Y; Li Y; Jasperson D; Henningson J; Lee J; Ma J; Li Y; Duff M; Liu H; Bai D; McVey S; Richt JA; Ikegami T; Wilson WC; Ma W
Vet Microbiol; 2019 Mar; 230():110-116. PubMed ID: 30827375
[TBL] [Abstract][Full Text] [Related]
2. High-Throughput Screening Using a Whole-Cell Virus Replication Reporter Gene Assay to Identify Inhibitory Compounds against Rift Valley Fever Virus Infection.
Islam MK; Baudin M; Eriksson J; Öberg C; Habjan M; Weber F; Överby AK; Ahlm C; Evander M
J Biomol Screen; 2016 Apr; 21(4):354-62. PubMed ID: 26762502
[TBL] [Abstract][Full Text] [Related]
3. Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.
Ikegami T; Hill TE; Smith JK; Zhang L; Juelich TL; Gong B; Slack OA; Ly HJ; Lokugamage N; Freiberg AN
J Virol; 2015 Jul; 89(14):7262-76. PubMed ID: 25948740
[TBL] [Abstract][Full Text] [Related]
4. Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment.
Scharton D; Bailey KW; Vest Z; Westover JB; Kumaki Y; Van Wettere A; Furuta Y; Gowen BB
Antiviral Res; 2014 Apr; 104():84-92. PubMed ID: 24486952
[TBL] [Abstract][Full Text] [Related]
5. Mouse model for the Rift Valley fever virus MP12 strain infection.
Lang Y; Henningson J; Jasperson D; Li Y; Lee J; Ma J; Li Y; Cao N; Liu H; Wilson W; Richt J; Ruder M; McVey S; Ma W
Vet Microbiol; 2016 Nov; 195():70-77. PubMed ID: 27771072
[TBL] [Abstract][Full Text] [Related]
6. Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challenge.
Gowen BB; Bailey KW; Scharton D; Vest Z; Westover JB; Skirpstunas R; Ikegami T
Antiviral Res; 2013 May; 98(2):135-43. PubMed ID: 23523764
[TBL] [Abstract][Full Text] [Related]
7. Protein Phosphatase-1 regulates Rift Valley fever virus replication.
Baer A; Shafagati N; Benedict A; Ammosova T; Ivanov A; Hakami RM; Terasaki K; Makino S; Nekhai S; Kehn-Hall K
Antiviral Res; 2016 Mar; 127():79-89. PubMed ID: 26801627
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR.
Nishiyama S; Slack OA; Lokugamage N; Hill TE; Juelich TL; Zhang L; Smith JK; Perez D; Gong B; Freiberg AN; Ikegami T
Virulence; 2016 Nov; 7(8):871-881. PubMed ID: 27248570
[TBL] [Abstract][Full Text] [Related]
9. Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.
Ikegami T
Expert Rev Vaccines; 2017 Jun; 16(6):601-611. PubMed ID: 28425834
[TBL] [Abstract][Full Text] [Related]
10. Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.
Ly HJ; Lokugamage N; Nishiyama S; Ikegami T
PLoS One; 2017; 12(9):e0185194. PubMed ID: 28926632
[TBL] [Abstract][Full Text] [Related]
11. Anti-Rift Valley fever virus activity in vitro, pre-clinical pharmacokinetics and oral bioavailability of benzavir-2, a broad-acting antiviral compound.
Islam MK; Strand M; Saleeb M; Svensson R; Baranczewski P; Artursson P; Wadell G; Ahlm C; Elofsson M; Evander M
Sci Rep; 2018 Jan; 8(1):1925. PubMed ID: 29386590
[TBL] [Abstract][Full Text] [Related]
12. The L, M, and S Segments of Rift Valley Fever Virus MP-12 Vaccine Independently Contribute to a Temperature-Sensitive Phenotype.
Nishiyama S; Lokugamage N; Ikegami T
J Virol; 2016 Jan; 90(7):3735-44. PubMed ID: 26819307
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania.
Nyundo S; Adamson E; Rowland J; Palermo PM; Matiko M; Bettinger GE; Wambura P; Morrill JC; Watts DM
Onderstepoort J Vet Res; 2019 Jan; 86(1):e1-e8. PubMed ID: 30843406
[TBL] [Abstract][Full Text] [Related]
14. Quantitative real-time PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compounds.
Garcia S; Crance JM; Billecocq A; Peinnequin A; Jouan A; Bouloy M; Garin D
J Clin Microbiol; 2001 Dec; 39(12):4456-61. PubMed ID: 11724861
[TBL] [Abstract][Full Text] [Related]
15. Sorafenib Impedes Rift Valley Fever Virus Egress by Inhibiting Valosin-Containing Protein Function in the Cellular Secretory Pathway.
Brahms A; Mudhasani R; Pinkham C; Kota K; Nasar F; Zamani R; Bavari S; Kehn-Hall K
J Virol; 2017 Nov; 91(21):. PubMed ID: 28794043
[TBL] [Abstract][Full Text] [Related]
16. Rift Valley fever virus 78kDa envelope protein attenuates virus replication in macrophage-derived cell lines and viral virulence in mice.
Terasaki K; Kalveram B; Johnson KN; Juelich T; Smith JK; Zhang L; Freiberg AN; Makino S
PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009785. PubMed ID: 34516560
[TBL] [Abstract][Full Text] [Related]
17. Identification of Rift Valley fever virus nucleocapsid protein-RNA binding inhibitors using a high-throughput screening assay.
Ellenbecker M; Lanchy JM; Lodmell JS
J Biomol Screen; 2012 Sep; 17(8):1062-70. PubMed ID: 22644268
[TBL] [Abstract][Full Text] [Related]
18. Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
Terasaki K; Tercero BR; Makino S
Virus Res; 2016 May; 216():55-65. PubMed ID: 26022573
[TBL] [Abstract][Full Text] [Related]
19. Galidesivir limits Rift Valley fever virus infection and disease in Syrian golden hamsters.
Westover JB; Mathis A; Taylor R; Wandersee L; Bailey KW; Sefing EJ; Hickerson BT; Jung KH; Sheridan WP; Gowen BB
Antiviral Res; 2018 Aug; 156():38-45. PubMed ID: 29864447
[TBL] [Abstract][Full Text] [Related]
20. Aerosol exposure to Rift Valley fever virus causes earlier and more severe neuropathology in the murine model, which has important implications for therapeutic development.
Reed C; Lin K; Wilhelmsen C; Friedrich B; Nalca A; Keeney A; Donnelly G; Shamblin J; Hensley LE; Olinger G; Smith DR
PLoS Negl Trop Dis; 2013; 7(4):e2156. PubMed ID: 23593523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
